Urge your members of Congress to support continued medical research funding
Today, ASH will convene laboratory investigators, clinical researchers, regulators, patient advocates, and industry leaders in Washington, DC, for the ASH Summit on Emerging Immunotherapies for Hematologic Diseases.
ASH has announced the names of five medical students selected to receive the 2018-2019 ASH Physician-Scientist Career Development Award. This award program allows students to gain valuable research experience in hematology under the mentorship of a revered ASH member.
ASH President Alexis Thompson, MD, called yesterday's Supreme Court decision upholding the president's authority to ban immigration from seven countries disappointing.
ASH will collaborate with the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, World Federation of Hemophilia, and the University of Kansas Medical Center to develop clinical practice guidelines on the diagnosis and management of von Willebrand Disease.
This World Sickle Cell Day, ASH hosted a webinar to raise global awareness about this devastating disease. Additionally, two new videos addressing the need for newborn screening and countering the prevailing myths about the disease in sub-Saharan Africa were unveiled.
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.
The American Society of Hematology has announced the names of the 35 hematologists participating in the 2018 ASH Clinical Research Training Institute in Latin America and Advanced CRTI-LA.
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study published online today in Blood Advances.
Today, ASH announced the names of 15 investigators who have been awarded $150,000 through the ASH Bridge Grant Program, supporting promising hematology research proposals that score well but cannot be funded by the National Institutes of Health (NIH) because of budget uncertainty.
ASH announced a partnership with the University of North Carolina at Chapel Hill, a National Institutes of Health Clinical Genome Resource grantee, to develop a broad and accessible compendium of genomic data aimed at improving the diagnosis of some blood cancers and disorders.
Urge your members of Congress to support continued medical research funding.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology